'Ocular hypertension treatment study' diaporamas de présentation

Landmark Glaucoma Studies

WHICH Patients ARE AT Risk for the PROGRESSION?. TARIQ ALASBALI. Landmark Glaucoma Studies. ``Doctor is my glaucoma likely to get worse?``. ``Doctor will my eye condition get worse?``. What is the diagnosis (OHT vs NTG vs POAG early or late ?)

1.17k views • 57 slides

GLAUCOMA

GLAUCOMA. Harold E. Cross M.D., Ph.D. 1-17-12 v. 8.0. (With contributions by T. Altenbernd, MD, and P. Tsai, MD). What is it? A disease of progressive optic neuropathy with loss of retinal neurons and their axons (nerve fiber layer) resulting in blindness if left untreated.

2.42k views • 50 slides

Key papers in glaucoma

526 views • 25 slides

12-Week, Randomized, Multicenter Study Comparing Fixed-Combination Brimonidine-Timolol and Timolol as Adjunctive Th

12-Week, Randomized, Multicenter Study Comparing Fixed-Combination Brimonidine-Timolol and Timolol as Adjunctive Therapy to Latanoprost.

287 views • 12 slides

Purpose: Study the correlations between corneal geometry (Pentacam) and biomechanical (ORA) properties with morphology

The study of the correlations of the optic disc size with Cornal Geometry and Biomechanical characteristics Fernanda B Fonyat,MD Renata Siqueira, MD; Guilhermo C Velarde, DSc Renato Ambrosio Jr, MD, PhD.

401 views • 11 slides

QUANTITATING THE IMPACT OF CLINICAL AND BASIC SCIENCE RESEARCH POSTER #2469

QUANTITATING THE IMPACT OF CLINICAL AND BASIC SCIENCE RESEARCH POSTER #2469. M. O. GORDON, C. SARLI, E. K. DUBINSKY, E. LONG, C. LA RUE, M. A. KASS, AND THE OCULAR HYPERTENSION TREATMENT STUDY (OHTS) GROUP.

99 views • 1 slides